Glecaprevir and pibrentasvir aid HCV-positive kidney transplants
(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys
Read more
(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys
Read moreA Virginia Commonwealth University researcher has published preliminary but striking evidence that shows the transplantation of gut bacteria may have
Read more